TP53 and cancer: By inhibiting this process, statins not only reduce cholesterol production but also impact by-products essential for cancer cell growth, thereby demonstrating their potential as anticancer agents.130,131 Of the statins, simvastatin is particularly interesting due to its anticancer applications, which have been observed in various cancer types and are largely mediated through activation of mutant P53.